RANBAXY FORMS JOINT VENTURE IN SOUTH AFRICA TO SUPPLY ARV MEDICINES FOR AFRICA MARKET

Ranbaxy Laboratories Limited (Ranbaxy), India's largest pharmaceutical company, and Community Investment Holdings (CIH), South Africa, have entered into an agreement to form a Joint Venture (JV) christened "Sonke Pharmaceuticals (Pty) Ltd", (Sonke), to market and sell Ranbaxy's range of Anti-Retroviral (ARV) products in South Africa and other African markets. Ranbaxy will hold 70% equity, while CIH will have a 30% stake in this JV.
Medical News Today